Your browser doesn't support javascript.
No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues.
Parry, Rhys; Gifford, Robert J; Lytras, Spyros; Ray, Stuart C; Coin, Lachlan J M.
  • Parry R; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia; r.parry@uq.edu.au lachlan.coin@unimelb.edu.au.
  • Gifford RJ; Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, United Kingdom.
  • Lytras S; Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, United Kingdom.
  • Ray SC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
  • Coin LJM; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; r.parry@uq.edu.au lachlan.coin@unimelb.edu.au.
Proc Natl Acad Sci U S A ; 118(33)2021 08 17.
Article in English | MEDLINE | ID: covidwho-1368987
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article